Health
A molecular trap against COVID-19 – Science Magazine
The cell surface peptidase angiotensin-converting enzyme 2 (ACE2) is the primary receptor for the spike (S) fusion protein that facilitates cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous studies are evaluating therapeutic…
The cell surface peptidase angiotensin-converting enzyme 2 (ACE2) is the primary receptor for the spike (S) fusion protein that facilitates cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous studies are evaluating therapeutic and preventive treatments that block S protein interactions with ACE2 molecules that are expressed on host cells. For example, the ACE2 binding site can be occluded by monoclonal antibodies, several of which are rapidly advancing in clinica…
-
General22 hours agoEmergency operation underway after reports of bodies north-east of Falls Creek
-
Noosa News23 hours agoExclusion zone declared as bushfire sparks major emergency response near Brisbane
-
Noosa News23 hours agoMan arrested after gaining ‘unauthorised’ access to Amberley RAAF base
-
Noosa News22 hours agoBroncos and Roosters set for ‘Queensland versus NSW rivalry’ in NRLW grand final